Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Different mechanisms of decreased drug accumulation in doxorubicin and mitoxantrone resistant variants of the MCF7 human breast cancer cell line

1 Dec 1991

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer therapeutics and mechanisms
Share to Drug Transport and Resistance Mechanisms
Share to Pharmacogenetics and Drug Metabolism

Source

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Identifiers

PMID: 1676902
DOI: 10.1038/bjc.1991.202

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Different mechanisms of decreased drug accumulation in doxorubicin and mitoxantrone resistant variants of the MCF7 human breast cancer cell linePMID 1676902Read ↗

Etoposide resistance in MCF-7 breast cancer cell line is marked by multiple mechanismsSemantic proximity Read ↗

The role of microRNAs on doxorubicin drug resistance in breast cancerSemantic proximity Read ↗

Doxorubicin pathways: pharmacodynamics and adverse effects.Semantic proximity Read ↗

Role of aldo-keto reductases and other doxorubicin pharmacokinetic genes in doxorubicin resistance, DNA binding, and subcellular localizationSemantic proximity Read ↗

Oxidative DNA base damage in MCF-10A breast epithelial cells at clinically achievable concentrations of doxorubicinSemantic proximity Read ↗

Mechanisms of multidrug resistance in cancer treatment.Semantic proximity Read ↗

Iron metabolism disturbances in the MCF-7 human breast cancer cells with acquired resistance to doxorubicin and cisplatinSemantic proximity Read ↗

Epigenetic and Cellular Reprogramming of Doxorubicin-Resistant MCF-7 Cells Treated with CurcuminSemantic proximity Read ↗

Extracellular concentration of anticancer drugs that regulates their intracellular distribution and binding to DNA in cells with multidrug resistant phenotype.Semantic proximity Read ↗

Role of DNA hypomethylation in the development of the resistance to doxorubicin in human MCF-7 breast adenocarcinoma cellsSemantic proximity Read ↗

Human breast cancer MCF-7 cell line contains inherently drug-resistant subclones with distinct genotypic and phenotypic features.Semantic proximity Read ↗

Epigenetic profiling of multidrug-resistant human MCF-7 breast adenocarcinoma cells reveals novel hyper- and hypomethylated targetsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.